Home > Boards > US Listed > Biotechs > Cerecor Inc (CERC)

i got 500 shares at .91

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
kseanng Member Profile
 
Followed By 3
Posts 509
Boards Moderated 0
Alias Born 07/18/16
160x600 placeholder
Cerecor Announces Proceeds from Option to Purchase Additional Shares of Common Stock Bringing Public Offering Proceeds to $40... GlobeNewswire Inc. - 1/20/2021 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/12/2021 5:23:38 PM
Cerecor Inc. Announces Closing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Inc. - 1/12/2021 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/8/2021 5:17:18 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/8/2021 5:03:26 PM
Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Inc. - 1/7/2021 10:03:21 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/7/2021 5:08:39 PM
Cerecor Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire Inc. - 1/7/2021 4:01:22 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/6/2021 4:48:23 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:25:31 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:14:16 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 1/5/2021 4:04:15 PM
Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing Antibody, in Patients Hospitaliz... GlobeNewswire Inc. - 1/5/2021 7:00:00 AM
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for the Treatment of Still’s Disease GlobeNewswire Inc. - 12/22/2020 1:00:00 PM
Cerecor Announces First Patient Dosed in a Phase 1b Clinical Trial of CERC-007 for the Treatment of Relapsed or Refractory Mu... GlobeNewswire Inc. - 12/16/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2020 4:17:49 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2020 4:13:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/14/2020 4:07:21 PM
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-007 for Treatment of Relapsed or Refractory... GlobeNewswire Inc. - 12/8/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 12/7/2020 6:27:06 PM
Cerecor Announces FDA Acceptance of Investigational New Drug Application for CERC-803 to Treat Leukocyte Adhesion Deficiency ... GlobeNewswire Inc. - 12/1/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/25/2020 6:06:43 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/20/2020 4:04:13 PM
Cerecor to Collaborate with Frontiers CDG Consortium on Pivotal Trial of CERC-801 for the Treatment of PGM1-CDG GlobeNewswire Inc. - 11/17/2020 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/9/2020 4:37:26 PM
kseanng   Monday, 03/13/17 10:03:13 PM
Re: stocktrademan post# 26
Post # of 202 
i got 500 shares at .91

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences